The Advantages Of Using Nolvadex

Nolvadex is the brand name for generic drug tamoxiferin. Tamoxiferin is known as antagonist substance for estrogen. It is also the first line of defense against carcinomas of breast. What makes Nolvadex different from other pharmaceutical products is that it is anabolic and androgenic steroid free.

There are several documented therapeutic uses of Nolvadex. It prevents excessive development of the breast in male or also known as gynecomastia. It works by completely joining to the estrogen receptors in the breast tissue and consequently prevents estrogen which is associated to breast development. Another recorded therapeutic use of Nolvadex is that it is successfully use as preventive medicine by people who are more prone for breast cancer. But, it is worth to remind the readers that not all breast cancers can be attributed to estrogen. Thus, there must be a comprehensive and extensive diagnosis and appropriate prognosis of a competent physician before using this meOLdicine.

People have mistaken belief that Nolvadex aids in burning of unwanted body fat which lead to the misuse and abuse of this product by people who want to have a sexy and gorgeous body. Nolvatex does not claim as a fat burning substance. However, it helps in keeping the estrogen least possible level of amount.

Moreover, Nolvadex is one of the well known anti – estrogen drugs used by athletes today. It is not only one of the most popular manufactured drug but it is also to purchase.

However, there are some rare unwanted side effects of Nolvadex such as vomiting, numbness, hot flashes, nausea, easy bruising, easy bleeding, swollen foot, unusual tiredness and blurred eyesight. It may also give the user some emotional effects such as mood fluctuations.

Furthermore, it may also lead to a loss of sexual interest and ability for men and irregular menstrual cycles for women. A complete missing of period or weaker menstrual bleeding may manifest for women who use this drug.

A word of warning. Never use this drug with letrozole or anastrozole because it is potentially lethal synergy of two drugs.

Related Posts:

NEW YORK (Reuters Health) - Data from the Women’s Health Initiative Observational Study show that higher than normal insulin levels are an independent risk factor for breast cancer. Study investigators, led by Dr. Marc J. Gunter at Albert Einstein College of Medicine in the Bronx, New York, examined the association between breast cancer and blood parameters

Full Post: High insulin levels may increase breast cancer risk

WASHINGTON (Reuters) - Certain breast cancer survivors who load up on fruits and vegetables, eating far more than current U.S. guidelines, can slash their risk the tumors will come back by nearly a third, according to a U.S. study released on Monday. The finding only held for women who did not have hot flashes after their

Full Post: Fruits, veggies slash breast cancer risk: U.S. study

LONDON (Reuters) - Joint damage suffered by people with rheumatoid arthritis may be caused by antibodies produced within the joint itself, British researchers said Tuesday in a study that may help development of new drugs. The study of joint biopsies from people with the condition which was then transplanted into mice found that tiny structures in

Full Post: Harmful enzyme may be key in rheumatoid arthritis

By Martha Kerr NEW YORK (Reuters Health) - As a woman’s menstrual cycle shortens with advancing age, her odds of becoming pregnant decreases, Swedish investigators report in the journal Fertility and Sterility. Dr. Thomas Brodin of Malarsjukhuset in Eskilstuna, Sweden, and colleagues analyzed successful pregnancy and delivery rates in 6,271 in vitro fertilization cycles in terms of

Full Post: Fertility declines with shorter menstrual cycles

By Michael Kahn LONDON (Reuters) - British scientists have figured out why some women develop resistance to the most commonly used breast cancer drug, something that raises the risk their tumors will return, according to a study published on Wednesday. The findings could lead to new tests to determine which women are not likely to benefit from

Full Post: Scientists unravel breast cancer drug resistance

Site Navigation

Most Read